Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Not Confirmed
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Not Confirmed
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Not Confirmed
Not Confirmed
12-14 January, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 February, 2026
BIO Partnering at JPMBIO Partnering at JPM
Industry Trade Show
Not Confirmed
12-15 January, 2026
Biotech ShowcaseBiotech Showcase
Industry Trade Show
Not Confirmed
12-14 January, 2026
Digital content

06 Sep 2024
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/connect-reduces-china-workforce-mulls-strategy-lead-asthma-drug

25 Feb 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/connect-biopharma-enhances-its-intellectual-property-estate-for-cbp-307-a-targeted-therapy-with-potential-in-multiple-autoimmune-diseases-with-patent-issuances-in-the-united-states-eu-japan-and-australia-301010279.html

08 Jan 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/connect-biopharma-reports-positive-topline-data-from-moderate-to-severe-atopic-dermatitis-ad-phase-1b-study-of-cbp-201-300983333.html

07 Jan 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/connect-biopharma-reports-positive-topline-data-from-moderate-to-severe-atopic-dermatitis-ad-phase-1b-study-of-cbp-201-300983333.html

07 Jan 2020
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/connect-biopharma-reports-positive-topline-data-from-moderate-to-severe-atopic-dermatitis-ad-phase-1b-study-of-cbp-201-300983333.html
ABOUT THIS PAGE